MNM‑siRNA IPF
Idiopathic pulmonary fibrosis
PreclinicalActive
Key Facts
About Interna TX
A platform biotech that uses a Molecular Nano Motor to deliver macromolecule drugs intracellularly for respiratory indications.
View full company profileTherapeutic Areas
Other Idiopathic pulmonary fibrosis Drugs
| Drug | Company | Phase |
|---|---|---|
| BIO 300 | Humanetics Corp. | Research |
| Undisclosed | Biossil | Phase 2/3 |
| KITCL27 | Kither Biotech | Preclinical |
| BRS101 | BreStem Therapeutics | Phase 1 |
| T03 | Treamid Therapeutics | Phase 1 |
| ING-006 | Innosphera Pharma | Preclinical |
| Pirfenidone | Gyre Therapeutics | Marketed |
| PIPE-791 | Contineum Therapeutics | Phase 1 |